Aflac Incorporated
AFL
Rangering i aksjer
#397
Aflac Incorporated, operating through its various subsidiary companies, focuses... Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
Aksjekurs
$120.12
Markedsverdi
$60.22B
Endring (1 dag)
1.13%
Endring (1 år)
10.43%
Land
US
Handel Aflac Incorporated (AFL)
Kategori
Financial Services
Antall utestående aksjer for Aflac Incorporated (AFL)
Antall utestående aksjer per June 2026: 504.12M
Ifølge Aflac Incorporated sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 504.12M. Ved slutten av December 2024 hadde selskapet 557.90M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Aflac Incorporated (AFL) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 504.12M | -4.89% |
| 2025 | 530.05M | -4.99% |
| 2024 | 557.90M | -6.42% |
| 2023 | 596.17M | -6.09% |
| 2022 | 634.82M | -5.76% |
| 2021 | 673.62M | -5.62% |
| 2020 | 713.70M | -3.87% |
| 2019 | 742.41M | -3.53% |
| 2018 | 769.59M | -2.83% |
| 2017 | 792.04M | -3.75% |
| 2016 | 822.94M | -4.45% |
| 2015 | 861.31M | -4.55% |
| 2014 | 902.41M | -2.86% |
| 2013 | 929.00M | -0.51% |
| 2012 | 933.74M | 0.07% |
| 2011 | 933.04M | -0.54% |
| 2010 | 938.08M | 0.53% |
| 2009 | 933.10M | -1.45% |
| 2008 | 946.81M | -2.96% |
| 2007 | 975.74M | -1.56% |
| 2006 | 991.23M | -1.06% |
| 2005 | 1.00B | -1.26% |
| 2004 | 1.01B | -1.15% |
| 2003 | 1.03B | -0.83% |
| 2002 | 1.04B | -1.44% |
| 2001 | 1.05B | -1.04% |
| 2000 | 1.06B | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 28.27B | 5,506.77% |
CN
|
|
| 10.42B | 1,967.15% |
HK
|
|
| - | - |
CA
|
|
| - | - |
TW
|
|
| - | - |
US
|
